Eesti -
eesti -
Ravimiamet
vancomycin cnp 1000 mg infusioonilahuse pulber
cnp pharma gmbh - vankomütsiin - infusioonilahuse pulber - 1000mg 5viaal; 1000mg 1viaal
Eesti -
eesti -
Ravimiamet
vancomycin cnp 500 mg infusioonilahuse pulber
cnp pharma gmbh - vankomütsiin - infusioonilahuse pulber - 500mg 5viaal
Eesti -
eesti -
Ravimiamet
amoxicillin-mip 750mg tablett
cnp pharma gmbh - amoksitsilliin - tablett - 750mg 16tk; 750mg 8tk
Euroopa Liit -
eesti -
EMA (European Medicines Agency)
voxzogo
biomarin international limited - vosoritide - achondroplasia - narkootikumid luuhaiguste raviks - voxzogo is indicated for the treatment of achondroplasia in patients 4 months of age and older whose epiphyses are not closed. the diagnosis of achondroplasia should be confirmed by appropriate genetic testing.
Euroopa Liit -
eesti -
EMA (European Medicines Agency)
ranivisio
midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmoloogilised vahendid - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).
Euroopa Liit -
eesti -
EMA (European Medicines Agency)
yesafili
viatris limited - aflibercept - macular edema; retinal vein occlusion; diabetic retinopathy; myopia, degenerative; diabetes complications - oftalmoloogilised vahendid - yesafili is indicated for adults for the treatment ofneovascular (wet) age-related macular degeneration (amd) (see section 5. 1),visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo) (see section 5. 1),visual impairment due to diabetic macular oedema (dme) (see section 5. 1),visual impairment due to myopic choroidal neovascularisation (myopic cnv) (see section 5.